Patent ID: 7862818

Claim:
A method of inhibiting chemokine binding to CCR5, comprising administering an isolated antibody or fragment thereof to an animal in need thereof, wherein the antibody or fragment thereof specifically binds a CCR5 polypeptide, and wherein the antibody or fragment thereof comprises: (a) the VH domain of the antibody expressed by the XF27/28.43E2 hybridoma cell line deposited under ATCC Deposit Accession Number PTA-4054 and the VL domain of the antibody expressed by the XF27/28.43E2 hybridoma cell line deposited under ATCC Deposit Accession Number PTA-4054; or (b) the VHCDR1, VHCDR2, VHCDR3, VLCDR1, VLCDR2, and VLCDR3 of the antibody expressed by the XF27/28.43E2 hybridoma cell line deposited under ATCC Deposit Accession Number PTA-4054.